TWD 5.04
(-1.95%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -14.56 Million USD | 37.02% |
2022 | -23.43 Million USD | -197.14% |
2021 | 24.37 Million USD | -83.15% |
2020 | 144.64 Million USD | 1405.62% |
2019 | 9.6 Million USD | 21.48% |
2018 | 5.05 Million USD | 54.39% |
2017 | 5.19 Million USD | -12.4% |
2016 | 5.29 Million USD | -12.43% |
2015 | 6.48 Million USD | -4.29% |
2014 | 5.33 Million USD | 4.35% |
2013 | 5.78 Million USD | -13.86% |
2012 | 7.69 Million USD | -19.14% |
2011 | 7.56 Million USD | 54.48% |
2010 | 6.21 Million USD | -2.48% |
2009 | 6.37 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -3.35 Million USD | 79.49% |
2023 FY | - USD | 37.02% |
2023 Q2 | -4.41 Million USD | 83.9% |
2023 Q4 | -16.34 Million USD | -270.0% |
2022 Q2 | -2.35 Million USD | -243.07% |
2022 FY | - USD | -197.14% |
2022 Q4 | -27.43 Million USD | -1067.28% |
2021 Q4 | -685 Thousand USD | -103.36% |
2021 Q2 | 20.37 Million USD | -78.76% |
2021 FY | - USD | -83.15% |
2020 Q2 | 44.24 Million USD | 1484.25% |
2020 Q4 | 95.92 Million USD | 116.78% |
2020 FY | - USD | 1405.62% |
2019 Q4 | 2.79 Million USD | 10.22% |
2019 Q2 | 2.53 Million USD | 1.12% |
2019 FY | - USD | 21.48% |
2018 Q4 | 2.5 Million USD | -1.61% |
2018 FY | - USD | 54.39% |
2018 Q2 | 2.54 Million USD | 19.07% |
2017 Q4 | 2.13 Million USD | -29.91% |
2017 Q2 | 3.05 Million USD | 38.73% |
2017 FY | - USD | -12.4% |
2016 FY | - USD | -12.43% |
2016 Q4 | 2.2 Million USD | -29.01% |
2016 Q2 | 3.09 Million USD | 10.84% |
2015 FY | - USD | -4.29% |
2015 Q4 | 2.79 Million USD | -24.27% |
2015 Q2 | 3.69 Million USD | 48.04% |
2014 Q2 | 2.84 Million USD | 32.51% |
2014 FY | - USD | 4.35% |
2014 Q4 | 2.49 Million USD | -12.34% |
2013 Q4 | 2.14 Million USD | -40.97% |
2013 FY | - USD | -13.86% |
2013 Q2 | 3.63 Million USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | -19.14% |
2011 Q2 | - USD | 0.0% |
2011 FY | - USD | 54.48% |
2011 Q4 | - USD | 0.0% |
2010 FY | - USD | -2.48% |
2010 Q4 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Nang Kuang Pharmaceutical Co., Ltd. | 402.69 Million TWD | 103.617% |
Maxigen Biotech Inc. | 177.09 Million TWD | 108.224% |
SciVision Biotech Inc. | 281.34 Million TWD | 105.177% |
Bionime Corporation | 179.78 Million TWD | 108.101% |
Pegavision Corporation | 2.91 Billion TWD | 100.499% |
Visco Vision Inc. | 733.58 Million TWD | 101.985% |